# Shift to Everolimus (RAD) Kidney Sparing Study

> **NCT00420537** · PHASE4 · TERMINATED · sponsor: **University of Bologna** · enrollment: 34 (actual)

## Conditions studied

- Kidney Dysfunction
- Heart Transplantation

## Interventions

- **DRUG:** cyclosporine
- **DRUG:** cyclosporine
- **DRUG:** Mycophenolate mofetil
- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT00420537
- **Lead sponsor:** University of Bologna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-09
- **Primary completion:** 2009-01
- **Final completion:** 2009-03
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** A cluster of adverse events in everolimus arm was noted.
- **Last updated:** 2010-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00420537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00420537, "Shift to Everolimus (RAD) Kidney Sparing Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00420537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*